We are live on
!
Find out more
MCM
Mason Capital Management Portfolio holdings
AUM
$613M
1-Year Est. Return
21.43%
This Fund
S&P 500
This Quarter
Est. Return
+13.49%
1 Year Est. Return
+21.43%
3 Year Est. Return
-17.99%
5 Year Est. Return
+51.94%
10 Year Est. Return
+270.99%
AUM
$8.4B
AUM Growth
+$3.9B
(+87%)
Cap. Flow
+$3.34B
Cap. Flow
% of AUM
39.72%
Top 10 Holdings %
Top 10 Hldgs %
53.13%
Holding
50
New
23
Increased
7
Reduced
5
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$539M |
| 2 |
AGN
Allergan Inc
AGN
|
+$427M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$266M |
| 4 |
AstraZeneca
AZN
|
+$242M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BWX Technologies
BWXT
|
+$358M |
| 2 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$248M |
| 3 |
Viatris
VTRS
|
+$144M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$90M |
| 5 |
Vodafone
VOD
|
+$86.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.19% |
| 2 | Energy | 20.63% |
| 3 | Technology | 16.33% |
| 4 | Communication Services | 9.68% |
| 5 | Consumer Discretionary | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APC
1
CALL
DELISTED
Anadarko Petroleum
APC
| $657M | 7.82% |
+6,000,000
| New | +$611M |
|
|
TFCF
2
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $557M | 6.63% |
+16,279,652
| New | +$539M |
|
3
Energy Transfer Partners
ET
$70.2B
| $550M | 6.55% |
18,673,658
-3,175,258
| -15% | -$80.3M |
|
4
YPF
YPF
$20B
| $514M | 6.11% |
15,715,962
| – | – |
|
|
AGN
5
DELISTED
Allergan Inc
AGN
| $464M | 5.53% |
+2,743,791
| New | +$427M |
|
|
APC
6
DELISTED
Anadarko Petroleum
APC
| $379M | 4.52% |
3,466,252
+2,216,384
| +177% | +$226M |
|
|
FRX
7
DELISTED
FOREST LABORATORIES INC
FRX
| $361M | 4.29% |
3,643,635
+482,755
| +15% | +$45M |
|
|
RGP
8
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
| $354M | 4.21% |
10,987,327
+7,678,352
| +232% | +$217M |
|
9
Micron Technology
MU
$928B
| $349M | 4.16% |
10,592,146
+1,195,000
| +13% | +$32.6M |
|
|
DTV
10
DELISTED
DIRECTV COM STK (DE)
DTV
| $278M | 3.31% |
+3,267,888
| New | +$266M |
|
|
11
AstraZeneca
AZN
$270B
| $249M | 2.96% |
+3,345,785
| New | +$242M |
|
|
TRQ
12
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $230M | 2.74% |
6,885,622
+1,885,622
| +38% | +$69.8M |
|
13
PUT
AT&T
T
$168B
| $220M | 2.62% |
+8,248,520
| New | +$221M |
|
|
LO
14
DELISTED
LORILLARD INC COM STK
LO
| $212M | 2.52% |
+3,473,343
| New | +$202M |
|
|
15
Thermo Fisher Scientific
TMO
$215B
| $211M | 2.52% |
1,790,915
-764,606
| -30% | -$90M |
|
|
EMC
16
DELISTED
EMC CORPORATION
EMC
| $208M | 2.48% |
7,908,317
| – | – |
|
17
Pfizer
PFE
$144B
| $199M | 2.37% |
7,058,232
+152,830
| +2% | +$4.36M |
|
18
McDonald's
MCD
$193B
| $196M | 2.33% |
+1,946,376
| New | +$196M |
|
|
ETP
19
DELISTED
Energy Transfer Partners L.p.
ETP
| $193M | 2.29% |
+3,324,597
| New | +$186M |
|
20
DuPont de Nemours
DD
$18.9B
| $193M | 2.29% |
+1,478,200
| New | +$188M |
|
|
HUB.B
21
DELISTED
HUBBELL INC CL-B
HUB.B
| $184M | 2.2% |
1,497,503
| – | – |
|
22
Applied Materials
AMAT
$373B
| $180M | 2.15% |
8,002,200
-2,350,000
| -23% | -$47.9M |
|
|
COV
23
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $171M | 2.03% |
+1,893,000
| New | +$142M |
|
|
24
Vodafone
VOD
$37.2B
| $156M | 1.85% |
4,662,682
-2,430,526
| -34% | -$86.1M |
|
|
MNK
25
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $119M | 1.42% |
+1,489,625
| New | +$108M |
|
Similar funds
PCA
PSP
CT
1SAMC
VV
DTL
CIP
FFWA
Mason Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Mason Capital Management held 50 positions worth $8.4B, up 87% from $4.5B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Mason Capital Management deployed $3.34B of net new capital in Q2 2014, opening 23 new positions and adding to 7 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 16,279,652 shares worth $557M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $90M trimmed.
- Mason Capital Management's largest Q2 2014 buy was Twenty-First Century Fox, Inc. Class B: 16,279,652 shares worth $557M.
- Mason Capital Management added most to Anadarko Petroleum in Q2 2014, an estimated $226M increase.
- Mason Capital Management's biggest Q2 2014 reduction was Thermo Fisher Scientific, cutting an estimated $90M.
- Mason Capital Management fully exited BWX Technologies in Q2 2014, selling an estimated $358M.
- Mason Capital Management's ten largest holdings make up 53% of its $8.4B portfolio in Q2 2014.
- Mason Capital Management opened 23 new positions and closed 5 in Q2 2014.
- Mason Capital Management's portfolio value rose 87% quarter-over-quarter to $8.4B.
Based on Mason Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.